Find clinical trials for Pancreatic Cancer in Birmingham, AL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Birmingham, AL, USA:
and clinical activity of ProAgio combined with gemcitabine and nab paclitaxel (G-nP) in previously untreated subjects with metastatic pancreatic...
Phase 1
Birmingham, Alabama, United States
A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™Capsules given daily for 21 days...
Phase 1
Birmingham, Alabama, United States and 6 other locations
liposome injection in combination with other approved drugs used for cancer therapy, namely 5 fluorouracil/leucovorin (5FU/LV) plus oxalipla ...
Phase 3
Birmingham, Alabama, United States and 199 other locations
To evaluate the efficacy of naporafenib administered with trametinib in patients with rat sarcoma viral oncogene (RAS) Q61X solid tumorsTo evaluate t...
Phase 1
Birmingham, Alabama, United States and 30 other locations
This study is about TAK-500, given either alone or with pembrolizumab, in adults with select locally advanced or metastatic solid tumors.The aims of...
Phase 1, Phase 2
Birmingham, Alabama, United States and 11 other locations
This study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors...
Phase 2
Birmingham, Alabama, United States and 41 other locations
This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with adva...
Phase 1, Phase 2
Birmingham, Alabama, United States and 97 other locations
This is a Phase 1, open-label, multicenter, dose-escalation and expansion study evaluating the safety, tolerability, PK, pharmacodynamics, and clinic...
Phase 1
Birmingham, Alabama, United States and 91 other locations
To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants wit...
Phase 1, Phase 2
Birmingham, Alabama, United States and 13 other locations
in participants with advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC), pancreatic duct adenocarcinoma (PDAC), biliary t...
Phase 1, Phase 2
Birmingham, Alabama, United States and 31 other locations
Clinical trials
Research sites
Resources
Legal